...
首页> 外文期刊>Experimental & Molecular Pathology >Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease
【24h】

Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease

机译:抗肾小球基底膜(GBM)抗体在患者中识别的表位,重复复发抗GBM疾病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The major epitopes recognized by autoantibodies in anti-glomerular basement membrane (GBM) disease are found in the alpha 3-subunit non-collagenous domain of type IV collagen [alpha 3(IV)NC1], which is present in the glomerular and alveolar basement membranes. These epitopes are structurally cryptic, owing to the hexamer formation of the non-collagenous domain of alpha 3, alpha 4, and alpha 5 subunits and are expressed by the dissociation of the hexamer. Anti-GBM disease usually manifests as a single attack (SA), and we rarely see patients who repeatedly relapse. We recently treated a patient with anti-GBM disease who exhibited repeated relapse (RR). Here, we conducted immunohistochemistry of formalin-fixed paraffin-embedded normal kidney sections and immunoblotting using recombinant human alpha 3(IV)NC1 to compare the epitopes recognized by anti-GBM antibodies in the RR patient and SA patients. Although a clear staining of GBM especially in the connecting basement membrane of Bowman's capsule was observed when IgGs of SA patients were used as primary antibodies, such staining was not obtained when IgG of the RR patient was employed. In immunoblotting of alpha 3(IV)NC1 using the IgG of the RR patient as a primary antibody, an 18-kDa band was detected besides the 56.8-kDa band corresponding to the whole-size alpha 3(IV)NC1. Whereas the 56.8-kDa band disappeared after digestion of the recombinant alpha 3(IV)NC1 by protease, the 18-kDa band remained. Furthermore, the 18-kDa band was not detected by a commercially available anti-alpha 3(IV)NC1 monoclonal antibody. These findings suggest that the IgG of the RR patient recognizes the epitope distinct from that recognized by the anti-alpha 3(IV)NC1 monoclonal antibody.
机译:在抗肾小球基底膜(GBM)疾病中识别的自身抗体识别的主要表位在IV型Ⅰ型胶原αα1]的α3-亚基非胶原结构域中存在,其存在于肾小球和肺泡基础上膜。由于α3,α4和α5亚基的非胶原结构结构域的六聚体形成,这些表位是在结构上隐蔽的,并且通过六聚体的解离表达。抗GBM疾病通常表现为单一攻击(SA),我们很少看到反复复发的患者。我们最近治疗了患有抗GBM疾病的患者,该抗GBM疾病表现出反复复发(RR)。在此,我们使用重组人α3(iv)NC1对福尔马林固定的石蜡包埋的正常肾切片和免疫印迹进行免疫组化,以比较RR患者和SA患者中抗GBM抗体认识到的表位。尽管在使用SA患者的IgG被用作原发性抗体时,观察到GBM的明确染色,但是在鲍曼胶囊的连接地下室膜中被观察到,但是当使用RR患者的IgG时,未获得这种染色。在使用RR患者的IgG作为一抗体的IgG免疫引起α3(iv)NC1中,除了对应于全尺寸α3(IV)NC1的56.8-KDA带之外检测18kDa带。虽然在通过蛋白酶消化重组α3(iv)NC1后消化了56.8-KDA带,但仍保持18-kda带。此外,通过市售的抗α3(iv)NC1单克隆抗体未检测到18kDA带。这些发现表明,RR患者的IgG识别出不同于抗α3(IV)NC1单克隆抗体识别的表位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号